Federal contract award
W81K0022P0111
KIT, APTIMA COMBO 2 CT/GC 250 TEST
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | W065 — Lease or Rental of Equipment: Medical, Dental, and Veterinary Equipment and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.8M |
| Current contract value | $2.4M |
| Potential contract value / ceiling | $2.4M |
| Start date | Oct 1, 2022 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2027 |
| Latest award activity | Jun 3, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 3, 2026 | P00017 | $-68.2K | FY26 OBLIGATION OF OPTION THREE FOR THE GENPRO HOLOGIC ANALYZER WITH REAGENTS FOR CRDAMC, FAR 52.222-90. |
| Mar 13, 2026 | P00016 | $0 | FY26 OBLIGATION OF OPTION THREE FOR THE GENPRO HOLOGIC ANALYZER WITH REAGENTS FOR CRDAMC |
| Dec 18, 2025 | P00015 | $465.6K | FY26 OBLIGATION OF OPTION THREE FOR THE GENPRO HOLOGIC ANALYZER WITH REAGENTS FOR CRDAMC |
| Aug 12, 2025 | P00014 | $219.6K | GENPRO HOLOGIC ANALYZER WITH REAGENTS |
| Apr 28, 2025 | P00013 | $0 | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Mar 24, 2025 | P00012 | $-322.1K | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Feb 24, 2025 | P00011 | $-54.9K | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Nov 4, 2024 | P00010 | $576.6K | FY25 FUND XOY2 KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Jun 25, 2024 | P00009 | $-81.4K | PANTHER HOLOGIC KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| May 2, 2024 | P00008 | $0 | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Apr 30, 2024 | P00007 | $0 | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Oct 13, 2023 | P00006 | $576.6K | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Aug 22, 2023 | P00005 | $-48.0K | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| May 22, 2023 | P00004 | $-258.1K | TEST KITS, ANALYZER EQUIPMENT, ENABLE MOLECULAR TESTING OF NEISSERIA GONORRHOEAE (GC), CHLAMYDIA TRACHOMATIS (CT), APTIMA HPV, HPV 16, 18/45 GENOTYPING, BACTERIAL VAGINITIS, VAGINAL TRICHOMONAS AND YEAST FDA APPROVED TESTING. |
| Mar 2, 2023 | P00003 | $-57.6K | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Feb 28, 2023 | P00002 | $0 | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Oct 24, 2022 | P00001 | $576.6K | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
| Apr 12, 2022 | 0 | $0 | KIT, APTIMA COMBO 2 CT/GC 250 TEST |
Estimated positioning window
Nov 1, 2026 – Mar 30, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-09-30 (333 days from calculation)
- +35 points
- 3 historical awards in this buyer and category group
- +10 points
- 18 recorded award transactions
- +10 points
- Latest award action: 2026-06-03
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.